prompt string | completion string | split string | pair_id string | ranking_query_id string | ranking_member_index int64 | ranking_candidate_row_count int64 | ranking_candidate_parent_count int64 | retrieval_parent_rank int64 | retrieval_parent_context_index int64 | retrieval_parent_context_count int64 | task_id string | source_id string | retrieval_strategy string | query_record_id string | retrieval_record_id string | query_benchmark_row_id string | retrieval_benchmark_row_id string | query_molecule_identity_key string | retrieval_molecule_identity_key string | query_smiles string | retrieval_smiles string | query_condition_group string | retrieval_condition_group string | query_condition_scope string | retrieval_condition_scope string | query_condition_atoms list | retrieval_condition_atoms list | candidate_context_relation string | query_source_record_count int64 | retrieval_source_record_count int64 | query_agreement_fraction float64 | retrieval_agreement_fraction float64 | query_gold_Y int64 | retrieval_gold_Y int64 | ranking_balance_label string | query_geometry_value float64 | retrieval_geometry_value float64 | absolute_geometry_difference float64 | calibration_sample_standard_deviation float64 | target_distribution dict | canonical_endpoint_key string | assay_concept string | measurement_kind string | metadata dict | absolute_canonical_value_difference float64 | standardized_canonical_value_difference float64 | sd_logistic_similarity float64 | target_train_sample_standard_deviation float64 | target_a float64 | target_b float64 | label_mode string | binary_label int64 | is_decisive bool | morgan_tanimoto_similarity float64 | graph_a_position int64 | graph_b_position int64 | graph_offset int64 | representation string | pair_bucket_key string | query_parent_id string | retrieval_parent_id string | query_scaffold string | retrieval_scaffold string | query_evidence dict | retrieval_evidence dict | bucket_total_record_count int64 | bucket_train_record_count int64 | bucket_train_parent_count int64 | evaluation_regime string | calibration_scope string | logit_geometry_transform string | query_source_payload_json string | retrieval_source_payload_json string | level string | level_family string | query_source_row_uid string | retrieval_source_row_uid string | upstream_pair_bucket_key string |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
You are comparing two experiments selected from similar assays.
The experimental details may differ.
Experiment A (known measurement)
<SMILES>C/C(=N\NC(=N)N)c1cnn(-c2ccc(C#CC3CCCC3)cc2)c1C</SMILES>
- Assay system: Caco-2 assay
- Endpoint: efflux_or_secretory_transport
- Extra details: Caco-2 assay indicates lack of P‐... | (B) | train | 332ebf13b4437f47d5260330b89bae8b17b4523e19cf560b47447f06d83548d8 | -1 | null | -1 | null | null | null | bioavailability_ma | fg | minority_first_separate_family_caps_repair_binary_75_25.v24.2 | bioavailability_ma:01a67bd72386dd241708f44110e5104613e3f3be78babb72bd7b2e8a908c874e | bioavailability_ma:0c9fca69a3d6fbf71d1f9f1b43bfaf75273c13e09393a36312412ea488650f37 | bioavailability_ma:01a67bd72386dd241708f44110e5104613e3f3be78babb72bd7b2e8a908c874e | bioavailability_ma:0c9fca69a3d6fbf71d1f9f1b43bfaf75273c13e09393a36312412ea488650f37 | ULSDMUVEXKOYBU-ZDUSSCGKSA-N | ZOXVZGMDTDJVFL-ZVHZXABRSA-N | CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12 | C/C(=N\NC(=N)N)c1cnn(-c2ccc(C#CC3CCCC3)cc2)c1C | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | exact_v10_pair_bucket_and_level | exact_v10_pair_bucket_and_level | [
"Assay system=Caco-2 bidirectional transport with inhibitor study",
"Endpoint=efflux_or_secretory_transport",
"Intestinal site=apical membrane",
"Molecule name=zolmitriptan",
"Qualifying conditions=Inhibited by verapamil, nifedipine, nimodipine",
"Transporter or enzyme=P-glycoprotein (ABCB1)"
] | [
"Assay system=Caco-2 assay",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=23",
"Transporter or enzyme=P-gp/ABCB1"
] | same_exact_v10_pair_bucket_and_level | 1 | 1 | null | null | 1 | 0 | far | 1 | 0 | 1 | null | {
"nontransfer": 0.9276884331807846,
"transfer": 0.07231156681921541
} | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | L5 | binary | {
"calibration_sha256": "ba5f07c876284074163b9ec5a6e974ff8b00efecae4679c6e0cbab7b47d0d8a0",
"groups": {
"assay_concept": "L5",
"measurement_kind": "binary",
"query_condition_group": "[\"fg\",\"efflux_or_secretory_transport\",\"binary_outcome_class\",\"fg_substrate_status_binary.v1\",\"ABCB1\",\"caco_2\"... | 1 | null | 0.072312 | null | 0.072312 | 0.927688 | query_disjoint_ratio_conflict_gated.v25 | 0 | true | 0.065217 | -1 | -1 | -1 | fg | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | ULSDMUVEXKOYBU-ZDUSSCGKSA-N | ZOXVZGMDTDJVFL-ZVHZXABRSA-N | O=C1NC(Cc2ccc3[nH]ccc3c2)CO1 | C(#CC1CCCC1)c1ccc(-n2cccn2)cc1 | {
"aggregation_method": "individual_record",
"display_measurement_text": "",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 1,
"aggregate_max": 1,
"aggregate_q1": 1,
"aggregate_q3": 1
} | {
"aggregation_method": "individual_record",
"display_measurement_text": "not a substrate for P-gp",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 0,
"aggregate_max": 0,
"aggregate_q1": 0,
"aggregat... | 1,264 | 1,102 | 354 | id | train_only_exact_bucket.v24 | identity | {"assay_system":"Caco-2 bidirectional transport with inhibitor study","confidence":0.94,"endpoint_name":"efflux_or_secretory_transport","extra_details":"Na+‐H+ exchanger inhibition increased absorption, indicating additional transport involvement.","extraction_id":"ext_2","global_identifier":"SMILES:1728358","intestina... | {"assay_system":"Caco-2 assay","confidence":0.96,"endpoint_name":"efflux_or_secretory_transport","extra_details":"Caco-2 assay indicates lack of P‐gp mediated efflux.","extraction_id":"ext_1","global_identifier":"SMILES:77593","intestinal_site":null,"measurement_text":"not a substrate for P-gp","molecule_name":"23","pa... | L5 | gut_wall_efflux_intestinal_metabolism | sr_61455d06268f4afa9c0ac8cfdb3c6b13 | sr_324aff2717974dd18eaf25550e11e4e7 | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__"] | |
You are comparing two experiments selected from similar assays.
The experimental details may differ.
Experiment A (known measurement)
<SMILES>COc1ccc(Oc2cc([N+](=O)[O-])ccc2NS(C)(=O)=O)cc1</SMILES>
- Assay system: Caco-2 cell transport study
- Endpoint: efflux_or_secretory_transport
- Extra details: Qualitative observ... | (B) | train | 9510d18d301326b98ff0f0c303947dc2cf1fd892db2ec085be108d99175e40c5 | -1 | null | -1 | null | null | null | bioavailability_ma | fg | minority_first_separate_family_caps_repair_binary_75_25.v24.2 | bioavailability_ma:6fb81db33f35bd9be731468ffa4af4f8be591189c283d4c230957c8ecb971693 | bioavailability_ma:29a9eeebba4fff05d5e10e133b9b8f722cec67976adef6508189bcb1c7df2846 | bioavailability_ma:6fb81db33f35bd9be731468ffa4af4f8be591189c283d4c230957c8ecb971693 | bioavailability_ma:29a9eeebba4fff05d5e10e133b9b8f722cec67976adef6508189bcb1c7df2846 | ULSDMUVEXKOYBU-ZDUSSCGKSA-N | OBTVYILXIRNVAP-UHFFFAOYSA-N | CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12 | COc1ccc(Oc2cc([N+](=O)[O-])ccc2NS(C)(=O)=O)cc1 | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | exact_v10_pair_bucket_and_level | exact_v10_pair_bucket_and_level | [
"Assay system=Caco-2 bidirectional transport",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=zolmitriptan",
"Transporter or enzyme=P-gp/ABCB1"
] | [
"Assay system=Caco-2 cell transport study",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=1d",
"Transporter or enzyme=P-gp/ABCB1"
] | same_exact_v10_pair_bucket_and_level | 1 | 1 | null | null | 1 | 0 | far | 1 | 0 | 1 | null | {
"nontransfer": 0.9276884331807846,
"transfer": 0.07231156681921541
} | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | L5 | binary | {
"calibration_sha256": "ba5f07c876284074163b9ec5a6e974ff8b00efecae4679c6e0cbab7b47d0d8a0",
"groups": {
"assay_concept": "L5",
"measurement_kind": "binary",
"query_condition_group": "[\"fg\",\"efflux_or_secretory_transport\",\"binary_outcome_class\",\"fg_substrate_status_binary.v1\",\"ABCB1\",\"caco_2\"... | 1 | null | 0.072312 | null | 0.072312 | 0.927688 | query_disjoint_ratio_conflict_gated.v25 | 0 | true | 0.075 | -1 | -1 | -1 | fg | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | ULSDMUVEXKOYBU-ZDUSSCGKSA-N | OBTVYILXIRNVAP-UHFFFAOYSA-N | O=C1NC(Cc2ccc3[nH]ccc3c2)CO1 | c1ccc(Oc2ccccc2)cc1 | {
"aggregation_method": "individual_record",
"display_measurement_text": "",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 1,
"aggregate_max": 1,
"aggregate_q1": 1,
"aggregate_q3": 1
} | {
"aggregation_method": "individual_record",
"display_measurement_text": "",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 0,
"aggregate_max": 0,
"aggregate_q1": 0,
"aggregate_q3": 0
} | 1,264 | 1,102 | 354 | id | train_only_exact_bucket.v24 | identity | {"assay_system":"Caco-2 bidirectional transport","confidence":0.96,"endpoint_name":"efflux_or_secretory_transport","extra_details":"Transport mediated by passive diffusion and P‐gp; efflux considered a limiting factor for oral bioavailability.","extraction_id":"ext_26","global_identifier":"SMILES:1728358","intestinal_s... | {"assay_system":"Caco-2 cell transport study","confidence":0.97,"endpoint_name":"efflux_or_secretory_transport","extra_details":"Qualitative observation that P-gp does not mediate transport of 1d in Caco-2 monolayers.","extraction_id":"ext_5","global_identifier":"SMILES:2305490","intestinal_site":null,"measurement_text... | L5 | gut_wall_efflux_intestinal_metabolism | sr_35cd1be6db8747b38308e0ad8fc58ff4 | sr_e4ef45ca8b574601aa3145309494b336 | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__"] | |
You are comparing two experiments selected from similar assays.
The experimental details may differ.
Experiment A (known measurement)
<SMILES>Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1</SMILES>
- Assay system: Caco-2 transport assay (AP→BL and BL→AP directions)
- Endpoint: efflux_or_secretory_transport
- Extra details: The same C... | (B) | train | 344d92e04925b99d327344ad1a195bdd3b5d5a737c300e32535eb5248e92ea08 | -1 | null | -1 | null | null | null | bioavailability_ma | fg | minority_first_separate_family_caps_repair_binary_75_25.v24.2 | bioavailability_ma:356db407dceb5bf12246050eca6f66184d17cd02078d434f4db3d1bc119b1260 | bioavailability_ma:9cacf927d23ebf031911302f86f403bc980ef62efece7db1bb2b2119396b4534 | bioavailability_ma:356db407dceb5bf12246050eca6f66184d17cd02078d434f4db3d1bc119b1260 | bioavailability_ma:9cacf927d23ebf031911302f86f403bc980ef62efece7db1bb2b2119396b4534 | ULSDMUVEXKOYBU-ZDUSSCGKSA-N | LUKBXSAWLPMMSZ-OWOJBTEDSA-N | CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12 | Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1 | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | exact_v10_pair_bucket_and_level | exact_v10_pair_bucket_and_level | [
"Assay system=Caco-2 cell monolayer with 0.5 mM verapamil added apically",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=zolmitriptan",
"Qualifying conditions=0.5 mM verapamil, added to apical side",
"Transporter or enzyme=P-gp/ABCB1"
] | [
"Assay system=Caco-2 transport assay (AP→BL and BL→AP directions)",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=trans-Resveratrol",
"Transporter or enzyme=P-glycoprotein/ABCB1"
] | same_exact_v10_pair_bucket_and_level | 1 | 1 | null | null | 1 | 0 | far | 1 | 0 | 1 | null | {
"nontransfer": 0.9276884331807846,
"transfer": 0.07231156681921541
} | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | L5 | binary | {
"calibration_sha256": "ba5f07c876284074163b9ec5a6e974ff8b00efecae4679c6e0cbab7b47d0d8a0",
"groups": {
"assay_concept": "L5",
"measurement_kind": "binary",
"query_condition_group": "[\"fg\",\"efflux_or_secretory_transport\",\"binary_outcome_class\",\"fg_substrate_status_binary.v1\",\"ABCB1\",\"caco_2\"... | 1 | null | 0.072312 | null | 0.072312 | 0.927688 | query_disjoint_ratio_conflict_gated.v25 | 0 | true | 0.064516 | -1 | -1 | -1 | fg | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | ULSDMUVEXKOYBU-ZDUSSCGKSA-N | LUKBXSAWLPMMSZ-OWOJBTEDSA-N | O=C1NC(Cc2ccc3[nH]ccc3c2)CO1 | C(=Cc1ccccc1)c1ccccc1 | {
"aggregation_method": "individual_record",
"display_measurement_text": "AP‐to‐BL 9.86 ± 0.87 nmol cm^-2 / 2 h (124 % of control); BL‐to‐AP 17.01 ± 0.92 nmol cm^-2 / 2 h (94 % of control)",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_reco... | {
"aggregation_method": "individual_record",
"display_measurement_text": "",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 0,
"aggregate_max": 0,
"aggregate_q1": 0,
"aggregate_q3": 0
} | 1,264 | 1,102 | 354 | id | train_only_exact_bucket.v24 | identity | {"assay_system":"Caco-2 cell monolayer with 0.5 mM verapamil added apically","confidence":0.97,"endpoint_name":"efflux_or_secretory_transport","extra_details":"Verapamil is a typical P‐gp inhibitor; increase in absorptive flux indicates P‐gp‐mediated efflux of zolmitriptan.","extraction_id":"ext_7","global_identifier":... | {"assay_system":"Caco-2 transport assay (AP→BL and BL→AP directions)","confidence":0.94,"endpoint_name":"efflux_or_secretory_transport","extra_details":"The same Caco‐2 cell monolayer model that expresses P‐gp and MRPs was used; lack of transport in the basolateral‐to‐apical direction indicated no P‐gp substrate activi... | L5 | gut_wall_efflux_intestinal_metabolism | sr_88f54bbfb00c42a3971f0bc6b5ec916d | sr_a72b5cffc5064be9881889df5ad90074 | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__"] | |
You are comparing two experiments selected from similar assays.
The experimental details may differ.
Experiment A (known measurement)
<SMILES>Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(OCCOCCOCCOCCNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)cc1)c1nnc(C)n1-2</SMILES>
- Assay system: Caco-2 cell uptake assay
- Endpoint: ... | (B) | train | 3d1066c9400c03cd06f30d0e575d123922245c319ed371983506216291f32122 | -1 | null | -1 | null | null | null | bioavailability_ma | fg | minority_first_separate_family_caps_repair_binary_75_25.v24.2 | bioavailability_ma:c7f2ab9b2f54960cb907cb5ef13e9eb9431f16a51d2d92231c7a0f5e32232cd3 | bioavailability_ma:6b152af1f72a91d4e5072312d567b0bab6cda2f8b3e621337e88a591866210b4 | bioavailability_ma:c7f2ab9b2f54960cb907cb5ef13e9eb9431f16a51d2d92231c7a0f5e32232cd3 | bioavailability_ma:6b152af1f72a91d4e5072312d567b0bab6cda2f8b3e621337e88a591866210b4 | ULSDMUVEXKOYBU-ZDUSSCGKSA-N | RWLOGRLTDKDANT-TYIYNAFKSA-N | CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12 | Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(OCCOCCOCCOCCNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)cc1)c1nnc(C)n1-2 | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | exact_v10_pair_bucket_and_level | exact_v10_pair_bucket_and_level | [
"Assay system=Caco-2 cell monolayer with 0.5 mM nimodipine added apically",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=zolmitriptan",
"Qualifying conditions=0.5 mM nimodipine, added to apical side",
"Transporter or enzyme=P-gp/ABCB1"
] | [
"Assay system=Caco-2 cell uptake assay",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=ARV-825",
"Transporter or enzyme=P-gp/ABCB1"
] | same_exact_v10_pair_bucket_and_level | 1 | 1 | null | null | 1 | 0 | far | 1 | 0 | 1 | null | {
"nontransfer": 0.9276884331807846,
"transfer": 0.07231156681921541
} | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | L5 | binary | {
"calibration_sha256": "ba5f07c876284074163b9ec5a6e974ff8b00efecae4679c6e0cbab7b47d0d8a0",
"groups": {
"assay_concept": "L5",
"measurement_kind": "binary",
"query_condition_group": "[\"fg\",\"efflux_or_secretory_transport\",\"binary_outcome_class\",\"fg_substrate_status_binary.v1\",\"ABCB1\",\"caco_2\"... | 1 | null | 0.072312 | null | 0.072312 | 0.927688 | query_disjoint_ratio_conflict_gated.v25 | 0 | true | 0.073529 | -1 | -1 | -1 | fg | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | ULSDMUVEXKOYBU-ZDUSSCGKSA-N | RWLOGRLTDKDANT-TYIYNAFKSA-N | O=C1NC(Cc2ccc3[nH]ccc3c2)CO1 | O=C1CCC(N2C(=O)c3cccc(NCCOCCOCCOCCOc4ccc(NC(=O)CC5N=C(c6ccccc6)c6ccsc6-n6cnnc65)cc4)c3C2=O)C(=O)N1 | {
"aggregation_method": "individual_record",
"display_measurement_text": "AP‐to‐BL 17.22 ± 3.20 nmol cm^-2 / 2 h (217 % of control); BL‐to‐AP 8.19 ± 0.04 nmol cm^-2 / 2 h (45 % of control)",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_reco... | {
"aggregation_method": "individual_record",
"display_measurement_text": "",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 0,
"aggregate_max": 0,
"aggregate_q1": 0,
"aggregate_q3": 0
} | 1,264 | 1,102 | 354 | id | train_only_exact_bucket.v24 | identity | {"assay_system":"Caco-2 cell monolayer with 0.5 mM nimodipine added apically","confidence":0.97,"endpoint_name":"efflux_or_secretory_transport","extra_details":"Nimodipine inhibition of P‐gp markedly increased net absorption of zolmitriptan.","extraction_id":"ext_9","global_identifier":"SMILES:1728358","intestinal_site... | {"assay_system":"Caco-2 cell uptake assay","confidence":0.98,"endpoint_name":"efflux_or_secretory_transport","extra_details":"Cell uptake assay indicated lack of P-gp mediated efflux for ARV-825.","extraction_id":"ext_1","global_identifier":"SMILES:2911370","intestinal_site":null,"measurement_text":null,"molecule_name"... | L5 | gut_wall_efflux_intestinal_metabolism | sr_672b147b7357443186b95b25e9f49ba4 | sr_82f75aa6431a4a03957ea59dbd0fa2d2 | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__"] | |
You are comparing two experiments selected from similar assays.
The experimental details may differ.
Experiment A (known measurement)
<SMILES>COc1ccc(CC(C)N)cc1</SMILES>
- Assay system: Caco-2 bidirectional transport
- Endpoint: efflux_or_secretory_transport
- Known source measurement: not a substrate for P‐gp‐mediate... | (B) | train | a9468cd1829efefff0f76e3165e1a874f40e6b7e7e5e08751c1d085a7a637f92 | -1 | null | -1 | null | null | null | bioavailability_ma | fg | minority_first_separate_family_caps_repair_binary_75_25.v24.2 | bioavailability_ma:356db407dceb5bf12246050eca6f66184d17cd02078d434f4db3d1bc119b1260 | bioavailability_ma:9351f446cdf1c3d39115b8cf8b33856f1710c0f027dd636660851b37a2858c0b | bioavailability_ma:356db407dceb5bf12246050eca6f66184d17cd02078d434f4db3d1bc119b1260 | bioavailability_ma:9351f446cdf1c3d39115b8cf8b33856f1710c0f027dd636660851b37a2858c0b | ULSDMUVEXKOYBU-ZDUSSCGKSA-N | NEGYEDYHPHMHGK-UHFFFAOYSA-N | CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12 | COc1ccc(CC(C)N)cc1 | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | exact_v10_pair_bucket_and_level | exact_v10_pair_bucket_and_level | [
"Assay system=Caco-2 cell monolayer with 0.5 mM verapamil added apically",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=zolmitriptan",
"Qualifying conditions=0.5 mM verapamil, added to apical side",
"Transporter or enzyme=P-gp/ABCB1"
] | [
"Assay system=Caco-2 bidirectional transport",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=p-MA",
"Qualifying conditions=tested with P‐gp inhibitors PSC‐833 and GF120918",
"Transporter or enzyme=P-gp/ABCB1"
] | same_exact_v10_pair_bucket_and_level | 1 | 1 | null | null | 1 | 0 | far | 1 | 0 | 1 | null | {
"nontransfer": 0.9276884331807846,
"transfer": 0.07231156681921541
} | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | L5 | binary | {
"calibration_sha256": "ba5f07c876284074163b9ec5a6e974ff8b00efecae4679c6e0cbab7b47d0d8a0",
"groups": {
"assay_concept": "L5",
"measurement_kind": "binary",
"query_condition_group": "[\"fg\",\"efflux_or_secretory_transport\",\"binary_outcome_class\",\"fg_substrate_status_binary.v1\",\"ABCB1\",\"caco_2\"... | 1 | null | 0.072312 | null | 0.072312 | 0.927688 | query_disjoint_ratio_conflict_gated.v25 | 0 | true | 0.111111 | -1 | -1 | -1 | fg | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | ULSDMUVEXKOYBU-ZDUSSCGKSA-N | NEGYEDYHPHMHGK-UHFFFAOYSA-N | O=C1NC(Cc2ccc3[nH]ccc3c2)CO1 | c1ccccc1 | {
"aggregation_method": "individual_record",
"display_measurement_text": "AP‐to‐BL 9.86 ± 0.87 nmol cm^-2 / 2 h (124 % of control); BL‐to‐AP 17.01 ± 0.92 nmol cm^-2 / 2 h (94 % of control)",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_reco... | {
"aggregation_method": "individual_record",
"display_measurement_text": "not a substrate for P‐gp‐mediated efflux",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 0,
"aggregate_max": 0,
"aggregate_q1"... | 1,264 | 1,102 | 354 | id | train_only_exact_bucket.v24 | identity | {"assay_system":"Caco-2 cell monolayer with 0.5 mM verapamil added apically","confidence":0.97,"endpoint_name":"efflux_or_secretory_transport","extra_details":"Verapamil is a typical P‐gp inhibitor; increase in absorptive flux indicates P‐gp‐mediated efflux of zolmitriptan.","extraction_id":"ext_7","global_identifier":... | {"assay_system":"Caco-2 bidirectional transport","confidence":0.95,"endpoint_name":"efflux_or_secretory_transport","extra_details":null,"extraction_id":"ext_22","global_identifier":"SMILES:2255939","intestinal_site":null,"measurement_text":"not a substrate for P‐gp‐mediated efflux","molecule_name":"p-MA","paragraph_idx... | L5 | gut_wall_efflux_intestinal_metabolism | sr_88f54bbfb00c42a3971f0bc6b5ec916d | sr_28d9b3feae844fe18d903ec1866a131b | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__"] | |
You are comparing two experiments selected from similar assays.
The experimental details may differ.
Experiment A (known measurement)
<SMILES>C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32O4</SMILES>
- Assay system: Caco-2 cells co‐incubated with R123 (fluorescent P‐gp substrate)
- Endpoint: efflux_or... | (B) | train | f24a97cb4c840c142aa30c2e47d3ff399dc852396fa172b7f78dede50f5ccdb7 | -1 | null | -1 | null | null | null | bioavailability_ma | fg | minority_first_separate_family_caps_repair_binary_75_25.v24.2 | bioavailability_ma:c7f2ab9b2f54960cb907cb5ef13e9eb9431f16a51d2d92231c7a0f5e32232cd3 | bioavailability_ma:cb41cf5da17a665ae08afb46926c111b50fcc14496b401faa30b08d481f7f607 | bioavailability_ma:c7f2ab9b2f54960cb907cb5ef13e9eb9431f16a51d2d92231c7a0f5e32232cd3 | bioavailability_ma:cb41cf5da17a665ae08afb46926c111b50fcc14496b401faa30b08d481f7f607 | ULSDMUVEXKOYBU-ZDUSSCGKSA-N | ZQGMLVQZBIKKMP-NNWCWBAJSA-N | CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12 | C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32O4 | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | exact_v10_pair_bucket_and_level | exact_v10_pair_bucket_and_level | [
"Assay system=Caco-2 cell monolayer with 0.5 mM nimodipine added apically",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=zolmitriptan",
"Qualifying conditions=0.5 mM nimodipine, added to apical side",
"Transporter or enzyme=P-gp/ABCB1"
] | [
"Assay system=Caco-2 cells co‐incubated with R123 (fluorescent P‐gp substrate)",
"Endpoint=efflux_or_secretory_transport",
"Intestinal site=apical membrane",
"Molecule name=5,6,7,8-tetrahydroxy-4'-methoxychalcone",
"Qualifying conditions=co‐incubation with DEART at experimental concentration",
"Transporte... | same_exact_v10_pair_bucket_and_level | 1 | 1 | null | null | 1 | 0 | far | 1 | 0 | 1 | null | {
"nontransfer": 0.9276884331807846,
"transfer": 0.07231156681921541
} | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | L5 | binary | {
"calibration_sha256": "ba5f07c876284074163b9ec5a6e974ff8b00efecae4679c6e0cbab7b47d0d8a0",
"groups": {
"assay_concept": "L5",
"measurement_kind": "binary",
"query_condition_group": "[\"fg\",\"efflux_or_secretory_transport\",\"binary_outcome_class\",\"fg_substrate_status_binary.v1\",\"ABCB1\",\"caco_2\"... | 1 | null | 0.072312 | null | 0.072312 | 0.927688 | query_disjoint_ratio_conflict_gated.v25 | 0 | true | 0.090909 | -1 | -1 | -1 | fg | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | ULSDMUVEXKOYBU-ZDUSSCGKSA-N | ZQGMLVQZBIKKMP-NNWCWBAJSA-N | O=C1NC(Cc2ccc3[nH]ccc3c2)CO1 | O=C1CC2CCCC3CCC4OC(O1)C32O4 | {
"aggregation_method": "individual_record",
"display_measurement_text": "AP‐to‐BL 17.22 ± 3.20 nmol cm^-2 / 2 h (217 % of control); BL‐to‐AP 8.19 ± 0.04 nmol cm^-2 / 2 h (45 % of control)",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_reco... | {
"aggregation_method": "individual_record",
"display_measurement_text": "inhibited R123 efflux similarly to verapamil (qualitative)",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 0,
"aggregate_max": 0... | 1,264 | 1,102 | 354 | id | train_only_exact_bucket.v24 | identity | {"assay_system":"Caco-2 cell monolayer with 0.5 mM nimodipine added apically","confidence":0.97,"endpoint_name":"efflux_or_secretory_transport","extra_details":"Nimodipine inhibition of P‐gp markedly increased net absorption of zolmitriptan.","extraction_id":"ext_9","global_identifier":"SMILES:1728358","intestinal_site... | {"assay_system":"Caco-2 cells co‐incubated with R123 (fluorescent P‐gp substrate)","confidence":0.94,"endpoint_name":"efflux_or_secretory_transport","extra_details":"DEART reduced the efflux ratio of R123, indicating inhibition of P‐gp‐mediated transport.","extraction_id":"ext_31","global_identifier":"SMILES:2483111","... | L5 | gut_wall_efflux_intestinal_metabolism | sr_672b147b7357443186b95b25e9f49ba4 | sr_2d578be65afa49b0894ab211d201e9e3 | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__"] | |
You are comparing two experiments selected from similar assays.
The experimental details may differ.
Experiment A (known measurement)
<SMILES>Cc1c(C(=O)c2cccc3ccccc23)c2cccc3c2n1[C@H](CN1CCOCC1)CO3</SMILES>
- Assay system: Caco-2 bidirectional transport
- Endpoint: efflux_or_secretory_transport
- Extra details: WIN-55... | (B) | train | 4c9e5c584ee64e818c2078e310ed10a6b996957ee557f53e5481de90e29ce227 | -1 | null | -1 | null | null | null | bioavailability_ma | fg | minority_first_separate_family_caps_repair_binary_75_25.v24.2 | bioavailability_ma:76c988b201bbe81abbe1cf4626413ccdd0c9f0817d6c8129ea24e91d4a38be1b | bioavailability_ma:5f614a6655012b40f8756db11a063cbabb43d0c6390171a7de041b964d1d328c | bioavailability_ma:76c988b201bbe81abbe1cf4626413ccdd0c9f0817d6c8129ea24e91d4a38be1b | bioavailability_ma:5f614a6655012b40f8756db11a063cbabb43d0c6390171a7de041b964d1d328c | ULSDMUVEXKOYBU-ZDUSSCGKSA-N | HQVHOQAKMCMIIM-HXUWFJFHSA-N | CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12 | Cc1c(C(=O)c2cccc3ccccc23)c2cccc3c2n1[C@H](CN1CCOCC1)CO3 | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | exact_v10_pair_bucket_and_level | exact_v10_pair_bucket_and_level | [
"Assay system=Caco-2 cell monolayer with 0.5 mM nifedipine added apically",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=zolmitriptan",
"Qualifying conditions=0.5 mM nifedipine, added to apical side",
"Transporter or enzyme=P-gp/ABCB1"
] | [
"Assay system=Caco-2 bidirectional transport",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=WIN-55,212-2",
"Qualifying conditions=5 µM concentration in Caco-2 monolayers",
"Transporter or enzyme=P-gp/ABCB1"
] | same_exact_v10_pair_bucket_and_level | 1 | 1 | null | null | 1 | 0 | far | 1 | 0 | 1 | null | {
"nontransfer": 0.9276884331807846,
"transfer": 0.07231156681921541
} | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | L5 | binary | {
"calibration_sha256": "ba5f07c876284074163b9ec5a6e974ff8b00efecae4679c6e0cbab7b47d0d8a0",
"groups": {
"assay_concept": "L5",
"measurement_kind": "binary",
"query_condition_group": "[\"fg\",\"efflux_or_secretory_transport\",\"binary_outcome_class\",\"fg_substrate_status_binary.v1\",\"ABCB1\",\"caco_2\"... | 1 | null | 0.072312 | null | 0.072312 | 0.927688 | query_disjoint_ratio_conflict_gated.v25 | 0 | true | 0.134831 | -1 | -1 | -1 | fg | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | ULSDMUVEXKOYBU-ZDUSSCGKSA-N | HQVHOQAKMCMIIM-HXUWFJFHSA-N | O=C1NC(Cc2ccc3[nH]ccc3c2)CO1 | O=C(c1cccc2ccccc12)c1cn2c3c(cccc13)OCC2CN1CCOCC1 | {
"aggregation_method": "individual_record",
"display_measurement_text": "AP‐to‐BL 12.85 ± 0.87 nmol cm^-2 / 2 h (162 % of control); BL‐to‐AP 12.52 ± 0.17 nmol cm^-2 / 2 h (69 % of control)",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_rec... | {
"aggregation_method": "individual_record",
"display_measurement_text": "not identified as substrate of P-gp in Caco-2 transport assay",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 0,
"aggregate_max"... | 1,264 | 1,102 | 354 | id | train_only_exact_bucket.v24 | identity | {"assay_system":"Caco-2 cell monolayer with 0.5 mM nifedipine added apically","confidence":0.97,"endpoint_name":"efflux_or_secretory_transport","extra_details":"Nifedipine is a P‐gp inhibitor; the marked reduction in efflux confirms P‐gp‐mediated transport.","extraction_id":"ext_8","global_identifier":"SMILES:1728358",... | {"assay_system":"Caco-2 bidirectional transport","confidence":0.98,"endpoint_name":"efflux_or_secretory_transport","extra_details":"WIN-55,212-2 was identified as a possible P-gp inhibitor in the activity range of verapamil.","extraction_id":"ext_53","global_identifier":"SMILES:2611659","intestinal_site":null,"measurem... | L5 | gut_wall_efflux_intestinal_metabolism | sr_753f6372e5e84b21bfd62875c1fa025d | sr_f3e688ac85ae443f8b54dce58148ba16 | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__"] | |
You are comparing two experiments selected from similar assays.
The experimental details may differ.
Experiment A (known measurement)
<SMILES>CO/N=C1\C[C@]2(C[C@@H]3C[C@@H](C/C=C(\C)C[C@@H](C)/C=C/C=C4\CO[C@@H]5[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]45O)O2)O[C@H](/C(C)=C/C(C)C)[C@H]1C</SMILES>
- Assay system: polarised CaCo... | (B) | train | e47ae0beeff60b62f6ea40a178dec55a68bbc3708cb99c998a142345e87ab04b | -1 | null | -1 | null | null | null | bioavailability_ma | fg | minority_first_separate_family_caps_repair_binary_75_25.v24.2 | bioavailability_ma:76c988b201bbe81abbe1cf4626413ccdd0c9f0817d6c8129ea24e91d4a38be1b | bioavailability_ma:66390cea8d9f3f115ec025ddd078f1e202ebe887587f8e0d42b267f8913916ba | bioavailability_ma:76c988b201bbe81abbe1cf4626413ccdd0c9f0817d6c8129ea24e91d4a38be1b | bioavailability_ma:66390cea8d9f3f115ec025ddd078f1e202ebe887587f8e0d42b267f8913916ba | ULSDMUVEXKOYBU-ZDUSSCGKSA-N | YZBLFMPOMVTDJY-LSGXYNIPSA-N | CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12 | CO/N=C1\C[C@]2(C[C@@H]3C[C@@H](C/C=C(\C)C[C@@H](C)/C=C/C=C4\CO[C@@H]5[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]45O)O2)O[C@H](/C(C)=C/C(C)C)[C@H]1C | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | exact_v10_pair_bucket_and_level | exact_v10_pair_bucket_and_level | [
"Assay system=Caco-2 cell monolayer with 0.5 mM nifedipine added apically",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=zolmitriptan",
"Qualifying conditions=0.5 mM nifedipine, added to apical side",
"Transporter or enzyme=P-gp/ABCB1"
] | [
"Assay system=polarised CaCo‐2 cell bidirectional transport assay",
"Endpoint=efflux_or_secretory_transport",
"Intestinal site=apical membrane",
"Molecule name=MOX",
"Transporter or enzyme=P-gp/ABCB1"
] | same_exact_v10_pair_bucket_and_level | 1 | 1 | null | null | 1 | 0 | far | 1 | 0 | 1 | null | {
"nontransfer": 0.9276884331807846,
"transfer": 0.07231156681921541
} | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | L5 | binary | {
"calibration_sha256": "ba5f07c876284074163b9ec5a6e974ff8b00efecae4679c6e0cbab7b47d0d8a0",
"groups": {
"assay_concept": "L5",
"measurement_kind": "binary",
"query_condition_group": "[\"fg\",\"efflux_or_secretory_transport\",\"binary_outcome_class\",\"fg_substrate_status_binary.v1\",\"ABCB1\",\"caco_2\"... | 1 | null | 0.072312 | null | 0.072312 | 0.927688 | query_disjoint_ratio_conflict_gated.v25 | 0 | true | 0.063492 | -1 | -1 | -1 | fg | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | ULSDMUVEXKOYBU-ZDUSSCGKSA-N | YZBLFMPOMVTDJY-LSGXYNIPSA-N | O=C1NC(Cc2ccc3[nH]ccc3c2)CO1 | N=C1CCOC2(C1)CC1CC(CC=CCCC=CC=C3COC4CC=CC(C(=O)O1)C34)O2 | {
"aggregation_method": "individual_record",
"display_measurement_text": "AP‐to‐BL 12.85 ± 0.87 nmol cm^-2 / 2 h (162 % of control); BL‐to‐AP 12.52 ± 0.17 nmol cm^-2 / 2 h (69 % of control)",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_rec... | {
"aggregation_method": "individual_record",
"display_measurement_text": "No apical transport observed",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 0,
"aggregate_max": 0,
"aggregate_q1": 0,
"aggr... | 1,264 | 1,102 | 354 | id | train_only_exact_bucket.v24 | identity | {"assay_system":"Caco-2 cell monolayer with 0.5 mM nifedipine added apically","confidence":0.97,"endpoint_name":"efflux_or_secretory_transport","extra_details":"Nifedipine is a P‐gp inhibitor; the marked reduction in efflux confirms P‐gp‐mediated transport.","extraction_id":"ext_8","global_identifier":"SMILES:1728358",... | {"assay_system":"polarised CaCo‐2 cell bidirectional transport assay","confidence":0.88,"endpoint_name":"efflux_or_secretory_transport","extra_details":"Compared to ivermectin which shows active transport.","extraction_id":"ext_24","global_identifier":"SMILES:1857187","intestinal_site":"apical membrane","measurement_te... | L5 | gut_wall_efflux_intestinal_metabolism | sr_753f6372e5e84b21bfd62875c1fa025d | sr_eca5efb4daf04620aa17b282c9e224de | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__"] | |
You are comparing two experiments selected from similar assays.
The experimental details may differ.
Experiment A (known measurement)
<SMILES>CC1(C)[C@H](C(=O)OCc2cccc(Oc3ccccc3)c2)[C@@H]1C=C(Cl)Cl</SMILES>
- Assay system: Caco-2 cells and MDCK-MDR1 cells (P‐gp overexpressing)
- Endpoint: efflux_or_secretory_transport... | (B) | train | 787afcb0d7af2694b1b2f34ece996190b04fe0a0d0432106fc784a5105cee1f9 | -1 | null | -1 | null | null | null | bioavailability_ma | fg | minority_first_separate_family_caps_repair_binary_75_25.v24.2 | bioavailability_ma:01a67bd72386dd241708f44110e5104613e3f3be78babb72bd7b2e8a908c874e | bioavailability_ma:1dfdd425fe65b4a49224a3fe0dc0c74a128ec469f6dc1c014d90d167ad54d24f | bioavailability_ma:01a67bd72386dd241708f44110e5104613e3f3be78babb72bd7b2e8a908c874e | bioavailability_ma:1dfdd425fe65b4a49224a3fe0dc0c74a128ec469f6dc1c014d90d167ad54d24f | ULSDMUVEXKOYBU-ZDUSSCGKSA-N | RLLPVAHGXHCWKJ-HKUYNNGSSA-N | CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12 | CC1(C)[C@H](C(=O)OCc2cccc(Oc3ccccc3)c2)[C@@H]1C=C(Cl)Cl | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | exact_v10_pair_bucket_and_level | exact_v10_pair_bucket_and_level | [
"Assay system=Caco-2 bidirectional transport with inhibitor study",
"Endpoint=efflux_or_secretory_transport",
"Intestinal site=apical membrane",
"Molecule name=zolmitriptan",
"Qualifying conditions=Inhibited by verapamil, nifedipine, nimodipine",
"Transporter or enzyme=P-glycoprotein (ABCB1)"
] | [
"Assay system=Caco-2 cells and MDCK-MDR1 cells (P‐gp overexpressing)",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=cis-permethrin",
"Transporter or enzyme=P-gp/ABCB1"
] | same_exact_v10_pair_bucket_and_level | 1 | 1 | null | null | 1 | 0 | far | 1 | 0 | 1 | null | {
"nontransfer": 0.9276884331807846,
"transfer": 0.07231156681921541
} | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | L5 | binary | {
"calibration_sha256": "ba5f07c876284074163b9ec5a6e974ff8b00efecae4679c6e0cbab7b47d0d8a0",
"groups": {
"assay_concept": "L5",
"measurement_kind": "binary",
"query_condition_group": "[\"fg\",\"efflux_or_secretory_transport\",\"binary_outcome_class\",\"fg_substrate_status_binary.v1\",\"ABCB1\",\"caco_2\"... | 1 | null | 0.072312 | null | 0.072312 | 0.927688 | query_disjoint_ratio_conflict_gated.v25 | 0 | true | 0.108434 | -1 | -1 | -1 | fg | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | ULSDMUVEXKOYBU-ZDUSSCGKSA-N | RLLPVAHGXHCWKJ-HKUYNNGSSA-N | O=C1NC(Cc2ccc3[nH]ccc3c2)CO1 | O=C(OCc1cccc(Oc2ccccc2)c1)C1CC1 | {
"aggregation_method": "individual_record",
"display_measurement_text": "",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 1,
"aggregate_max": 1,
"aggregate_q1": 1,
"aggregate_q3": 1
} | {
"aggregation_method": "individual_record",
"display_measurement_text": "",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 0,
"aggregate_max": 0,
"aggregate_q1": 0,
"aggregate_q3": 0
} | 1,264 | 1,102 | 354 | id | train_only_exact_bucket.v24 | identity | {"assay_system":"Caco-2 bidirectional transport with inhibitor study","confidence":0.94,"endpoint_name":"efflux_or_secretory_transport","extra_details":"Na+‐H+ exchanger inhibition increased absorption, indicating additional transport involvement.","extraction_id":"ext_2","global_identifier":"SMILES:1728358","intestina... | {"assay_system":"Caco-2 cells and MDCK-MDR1 cells (P‐gp overexpressing)","confidence":0.96,"endpoint_name":"efflux_or_secretory_transport","extra_details":"Qualitative observation; no decrease in uptake in P‐gp overexpressing cells","extraction_id":"ext_33","global_identifier":"SMILES:848781","intestinal_site":null,"me... | L5 | gut_wall_efflux_intestinal_metabolism | sr_61455d06268f4afa9c0ac8cfdb3c6b13 | sr_e5b46fe923a949b483621894119a9453 | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__"] | |
You are comparing two experiments selected from similar assays.
The experimental details may differ.
Experiment A (known measurement)
<SMILES>COc1cc2c(c(OC)c1OC)-c1c(cc(OC)c(OC)c1OC)C[C@@](C)(O)[C@@H](C)C2</SMILES>
- Assay system: Caco‐2 bidirectional transport assay
- Endpoint: efflux_or_secretory_transport
- Extra d... | (B) | train | 2a69ab1a66c7fb18809148a14ebb46b77970918691c031376288499324462083 | -1 | null | -1 | null | null | null | bioavailability_ma | fg | minority_first_separate_family_caps_repair_binary_75_25.v24.2 | bioavailability_ma:7ce12fe6407e535ffdd45658484f6b8cc4851be58d4b125d794354e7d6a866c8 | bioavailability_ma:26596d9c8add73d54dec114412feafd3a9c938c4d0891b284cbc1965b88fe6e6 | bioavailability_ma:7ce12fe6407e535ffdd45658484f6b8cc4851be58d4b125d794354e7d6a866c8 | bioavailability_ma:26596d9c8add73d54dec114412feafd3a9c938c4d0891b284cbc1965b88fe6e6 | ULSDMUVEXKOYBU-ZDUSSCGKSA-N | YEFOAORQXAOVJQ-RKNYENMMSA-N | CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12 | COc1cc2c(c(OC)c1OC)-c1c(cc(OC)c(OC)c1OC)C[C@@](C)(O)[C@@H](C)C2 | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | exact_v10_pair_bucket_and_level | exact_v10_pair_bucket_and_level | [
"Assay system=Caco-2 bidirectional transport assay",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=zolmitriptan",
"Transporter or enzyme=P-gp/ABCB1"
] | [
"Assay system=Caco‐2 bidirectional transport assay",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=schisandrol A",
"Transporter or enzyme=P-gp/ABCB1"
] | same_exact_v10_pair_bucket_and_level | 1 | 1 | null | null | 1 | 0 | far | 1 | 0 | 1 | null | {
"nontransfer": 0.9276884331807846,
"transfer": 0.07231156681921541
} | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | L5 | binary | {
"calibration_sha256": "ba5f07c876284074163b9ec5a6e974ff8b00efecae4679c6e0cbab7b47d0d8a0",
"groups": {
"assay_concept": "L5",
"measurement_kind": "binary",
"query_condition_group": "[\"fg\",\"efflux_or_secretory_transport\",\"binary_outcome_class\",\"fg_substrate_status_binary.v1\",\"ABCB1\",\"caco_2\"... | 1 | null | 0.072312 | null | 0.072312 | 0.927688 | query_disjoint_ratio_conflict_gated.v25 | 0 | true | 0.093333 | -1 | -1 | -1 | fg | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | ULSDMUVEXKOYBU-ZDUSSCGKSA-N | YEFOAORQXAOVJQ-RKNYENMMSA-N | O=C1NC(Cc2ccc3[nH]ccc3c2)CO1 | c1ccc2c(c1)CCCCc1ccccc1-2 | {
"aggregation_method": "individual_record",
"display_measurement_text": "P‐ratio (BL‐to‐AP / AP‐to‐BL) ≈ 1.5–2.6",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 1,
"aggregate_max": 1,
"aggregate_q1":... | {
"aggregation_method": "individual_record",
"display_measurement_text": "",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 0,
"aggregate_max": 0,
"aggregate_q1": 0,
"aggregate_q3": 0
} | 1,264 | 1,102 | 354 | id | train_only_exact_bucket.v24 | identity | {"assay_system":"Caco-2 bidirectional transport assay","confidence":0.93,"endpoint_name":"efflux_or_secretory_transport","extra_details":"Transport measured after 2 h with 0.8 mM zolmitriptan; n=4.","extraction_id":"ext_21","global_identifier":"SMILES:1728358","intestinal_site":null,"measurement_text":"P‐ratio (BL‐to‐A... | {"assay_system":"Caco‐2 bidirectional transport assay","confidence":0.94,"endpoint_name":"efflux_or_secretory_transport","extra_details":"transport study indicated lack of P‐gp mediated efflux","extraction_id":"ext_7","global_identifier":"SMILES:2160141","intestinal_site":null,"measurement_text":null,"molecule_name":"s... | L5 | gut_wall_efflux_intestinal_metabolism | sr_433bd88aef6140bc99e8ec3277a97947 | sr_2a9d0d6ccc4140c7809ca7ea872ae98f | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__"] | |
You are comparing two experiments selected from similar assays.
The experimental details may differ.
Experiment A (known measurement)
<SMILES>O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1</SMILES>
- Assay system: Caco-2 CLEFF9 cell bidirectional transport assay
- Endpoint: efflux_or_secretory_transport
- Extra details: No P‐gp in... | (B) | train | 0a5c2bfa4b0979bc08853d8386ac7fe13f0692f6db4389c7123af7e03184eb79 | -1 | null | -1 | null | null | null | bioavailability_ma | fg | minority_first_separate_family_caps_repair_binary_75_25.v24.2 | bioavailability_ma:356db407dceb5bf12246050eca6f66184d17cd02078d434f4db3d1bc119b1260 | bioavailability_ma:bffd4b494a5a38341d278c63701608f0334fed060c4be55d5ce7c4192138f598 | bioavailability_ma:356db407dceb5bf12246050eca6f66184d17cd02078d434f4db3d1bc119b1260 | bioavailability_ma:bffd4b494a5a38341d278c63701608f0334fed060c4be55d5ce7c4192138f598 | ULSDMUVEXKOYBU-ZDUSSCGKSA-N | CXOFVDLJLONNDW-UHFFFAOYSA-N | CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12 | O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1 | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | exact_v10_pair_bucket_and_level | exact_v10_pair_bucket_and_level | [
"Assay system=Caco-2 cell monolayer with 0.5 mM verapamil added apically",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=zolmitriptan",
"Qualifying conditions=0.5 mM verapamil, added to apical side",
"Transporter or enzyme=P-gp/ABCB1"
] | [
"Assay system=Caco-2 CLEFF9 cell bidirectional transport assay",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=phenytoin",
"Transporter or enzyme=P-gp/ABCB1"
] | same_exact_v10_pair_bucket_and_level | 1 | 1 | null | null | 1 | 0 | far | 1 | 0 | 1 | null | {
"nontransfer": 0.9276884331807846,
"transfer": 0.07231156681921541
} | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | L5 | binary | {
"calibration_sha256": "ba5f07c876284074163b9ec5a6e974ff8b00efecae4679c6e0cbab7b47d0d8a0",
"groups": {
"assay_concept": "L5",
"measurement_kind": "binary",
"query_condition_group": "[\"fg\",\"efflux_or_secretory_transport\",\"binary_outcome_class\",\"fg_substrate_status_binary.v1\",\"ABCB1\",\"caco_2\"... | 1 | null | 0.072312 | null | 0.072312 | 0.927688 | query_disjoint_ratio_conflict_gated.v25 | 0 | true | 0.095238 | -1 | -1 | -1 | fg | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | ULSDMUVEXKOYBU-ZDUSSCGKSA-N | CXOFVDLJLONNDW-UHFFFAOYSA-N | O=C1NC(Cc2ccc3[nH]ccc3c2)CO1 | O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1 | {
"aggregation_method": "individual_record",
"display_measurement_text": "AP‐to‐BL 9.86 ± 0.87 nmol cm^-2 / 2 h (124 % of control); BL‐to‐AP 17.01 ± 0.92 nmol cm^-2 / 2 h (94 % of control)",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_reco... | {
"aggregation_method": "individual_record",
"display_measurement_text": "",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 0,
"aggregate_max": 0,
"aggregate_q1": 0,
"aggregate_q3": 0
} | 1,264 | 1,102 | 354 | id | train_only_exact_bucket.v24 | identity | {"assay_system":"Caco-2 cell monolayer with 0.5 mM verapamil added apically","confidence":0.97,"endpoint_name":"efflux_or_secretory_transport","extra_details":"Verapamil is a typical P‐gp inhibitor; increase in absorptive flux indicates P‐gp‐mediated efflux of zolmitriptan.","extraction_id":"ext_7","global_identifier":... | {"assay_system":"Caco-2 CLEFF9 cell bidirectional transport assay","confidence":0.94,"endpoint_name":"efflux_or_secretory_transport","extra_details":"No P‐gp involvement detected despite prior suggestions.","extraction_id":"ext_56","global_identifier":"SMILES:3809557","intestinal_site":null,"measurement_text":null,"mol... | L5 | gut_wall_efflux_intestinal_metabolism | sr_88f54bbfb00c42a3971f0bc6b5ec916d | sr_334a83b2157842479744c01d4ea12529 | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__"] | |
You are comparing two experiments selected from similar assays.
The experimental details may differ.
Experiment A (known measurement)
<SMILES>CO[C@H]1C(=O)[C@]2(C)[C@@H](OC(=O)N(C)C)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C1C2(C)C</SMILES>
- ... | (B) | train | 7f19059513abf61c0f285a3722a4885167f2ace67194194fe3e8a00d14204ac0 | -1 | null | -1 | null | null | null | bioavailability_ma | fg | minority_first_separate_family_caps_repair_binary_75_25.v24.2 | bioavailability_ma:7ce12fe6407e535ffdd45658484f6b8cc4851be58d4b125d794354e7d6a866c8 | bioavailability_ma:678fe6c7e91cca7f1620d23cfa91ec38dc885815ae09bb7c19863d3e6dd117fb | bioavailability_ma:7ce12fe6407e535ffdd45658484f6b8cc4851be58d4b125d794354e7d6a866c8 | bioavailability_ma:678fe6c7e91cca7f1620d23cfa91ec38dc885815ae09bb7c19863d3e6dd117fb | ULSDMUVEXKOYBU-ZDUSSCGKSA-N | XVZNFAAFLPHWPJ-LPJXRXTRSA-N | CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12 | CO[C@H]1C(=O)[C@]2(C)[C@@H](OC(=O)N(C)C)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C1C2(C)C | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | exact_v10_pair_bucket_and_level | exact_v10_pair_bucket_and_level | [
"Assay system=Caco-2 bidirectional transport assay",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=zolmitriptan",
"Transporter or enzyme=P-gp/ABCB1"
] | [
"Assay system=Caco-2 bidirectional permeability assay",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=T-13",
"Transporter or enzyme=P-gp/ABCB1"
] | same_exact_v10_pair_bucket_and_level | 1 | 1 | null | null | 1 | 0 | far | 1 | 0 | 1 | null | {
"nontransfer": 0.9276884331807846,
"transfer": 0.07231156681921541
} | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | L5 | binary | {
"calibration_sha256": "ba5f07c876284074163b9ec5a6e974ff8b00efecae4679c6e0cbab7b47d0d8a0",
"groups": {
"assay_concept": "L5",
"measurement_kind": "binary",
"query_condition_group": "[\"fg\",\"efflux_or_secretory_transport\",\"binary_outcome_class\",\"fg_substrate_status_binary.v1\",\"ABCB1\",\"caco_2\"... | 1 | null | 0.072312 | null | 0.072312 | 0.927688 | query_disjoint_ratio_conflict_gated.v25 | 0 | true | 0.090226 | -1 | -1 | -1 | fg | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__","L5"] | ULSDMUVEXKOYBU-ZDUSSCGKSA-N | XVZNFAAFLPHWPJ-LPJXRXTRSA-N | O=C1NC(Cc2ccc3[nH]ccc3c2)CO1 | O=C(CCc1ccccc1)OC1C=C2CC(=O)C3CCC4OCC4C3C(OC(=O)c3ccccc3)C(C2)C1 | {
"aggregation_method": "individual_record",
"display_measurement_text": "P‐ratio (BL‐to‐AP / AP‐to‐BL) ≈ 1.5–2.6",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 1,
"aggregate_max": 1,
"aggregate_q1":... | {
"aggregation_method": "individual_record",
"display_measurement_text": "",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 0,
"aggregate_max": 0,
"aggregate_q1": 0,
"aggregate_q3": 0
} | 1,264 | 1,102 | 354 | id | train_only_exact_bucket.v24 | identity | {"assay_system":"Caco-2 bidirectional transport assay","confidence":0.93,"endpoint_name":"efflux_or_secretory_transport","extra_details":"Transport measured after 2 h with 0.8 mM zolmitriptan; n=4.","extraction_id":"ext_21","global_identifier":"SMILES:1728358","intestinal_site":null,"measurement_text":"P‐ratio (BL‐to‐A... | {"assay_system":"Caco-2 bidirectional permeability assay","confidence":0.96,"endpoint_name":"efflux_or_secretory_transport","extra_details":"enhanced A-to-B transport observed","extraction_id":"ext_26","global_identifier":"SMILES:2052542","intestinal_site":null,"measurement_text":null,"molecule_name":"T-13","paragraph_... | L5 | gut_wall_efflux_intestinal_metabolism | sr_433bd88aef6140bc99e8ec3277a97947 | sr_c49c491f900c40999c0a90c1cee28583 | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","caco_2","__unknown__"] | |
You are comparing two experiments selected from similar assays.
The experimental details may differ.
Experiment A (known measurement)
<SMILES>CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1</SMILES>
- Assay system: MDCK-MDR1 cell monolayer bidirectional transport
- Endpoint: efflux_or_secretory_transport
- Extra details: MDC... | (B) | train | a64991099faf0a6c7df0b04922c2e2f36b234af5424d7ee4d2d10cf45fe99e78 | -1 | null | -1 | null | null | null | bioavailability_ma | fg | minority_first_separate_family_caps_repair_binary_75_25.v24.2 | bioavailability_ma:114a736f05a78d7d7faf4cba52eb19a734cf27d07ea7d25381d343d99c4145a3 | bioavailability_ma:a79917799db3d8a5229198b8e4f518425adf147fec7e31ed68bd0f1fb9120334 | bioavailability_ma:114a736f05a78d7d7faf4cba52eb19a734cf27d07ea7d25381d343d99c4145a3 | bioavailability_ma:a79917799db3d8a5229198b8e4f518425adf147fec7e31ed68bd0f1fb9120334 | YBHILYKTIRIUTE-UHFFFAOYSA-N | XIQVNETUBQGFHX-UHFFFAOYSA-N | COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-] | CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1 | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | exact_v10_pair_bucket_and_level | exact_v10_pair_bucket_and_level | [
"Assay system=MDR1-MDCK monolayer",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=berberine hydrochloride",
"Qualifying conditions=coformulated with natural nanoparticles",
"Transporter or enzyme=P-gp"
] | [
"Assay system=MDCK-MDR1 cell monolayer bidirectional transport",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=Oxybutynin",
"Transporter or enzyme=P-gp/ABCB1"
] | same_exact_v10_pair_bucket_and_level | 1 | 1 | null | null | 1 | 0 | far | 1 | 0 | 1 | null | {
"nontransfer": 0.9276884331807846,
"transfer": 0.07231156681921541
} | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | L5 | binary | {
"calibration_sha256": "ba5f07c876284074163b9ec5a6e974ff8b00efecae4679c6e0cbab7b47d0d8a0",
"groups": {
"assay_concept": "L5",
"measurement_kind": "binary",
"query_condition_group": "[\"fg\",\"efflux_or_secretory_transport\",\"binary_outcome_class\",\"fg_substrate_status_binary.v1\",\"ABCB1\",\"mdck\",\... | 1 | null | 0.072312 | null | 0.072312 | 0.927688 | query_disjoint_ratio_conflict_gated.v25 | 0 | true | 0.070588 | -1 | -1 | -1 | fg | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | YBHILYKTIRIUTE-UHFFFAOYSA-N | XIQVNETUBQGFHX-UHFFFAOYSA-N | c1ccc2c[n+]3c(cc2c1)-c1cc2c(cc1CC3)OCO2 | c1ccc(CC2CCCCC2)cc1 | {
"aggregation_method": "individual_record",
"display_measurement_text": "efflux ratio decreased from 25.8 to 17.1",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 1,
"aggregate_max": 1,
"aggregate_q1"... | {
"aggregation_method": "individual_record",
"display_measurement_text": "efflux ratio < 2 (unlikely P‐gp substrate)",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 0,
"aggregate_max": 0,
"aggregate_q... | 219 | 191 | 107 | id | train_only_exact_bucket.v24 | identity | {"assay_system":"MDR1-MDCK monolayer","confidence":0.96,"endpoint_name":"efflux_or_secretory_transport","extra_details":null,"extraction_id":"ext_9","global_identifier":"SMILES:2345041","intestinal_site":null,"measurement_text":"efflux ratio decreased from 25.8 to 17.1","molecule_name":"berberine hydrochloride","paragr... | {"assay_system":"MDCK-MDR1 cell monolayer bidirectional transport","confidence":0.93,"endpoint_name":"efflux_or_secretory_transport","extra_details":"MDCK-MDR1 cells overexpress human P‐gp.","extraction_id":"ext_13","global_identifier":"SMILES:1400781","intestinal_site":null,"measurement_text":"efflux ratio < 2 (unlike... | L5 | gut_wall_efflux_intestinal_metabolism | sr_e62e36898f0248f28d38df6e2ba3b704 | sr_48201f525b364d90be70cca4ea5a8c6d | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__"] | |
You are comparing two experiments selected from similar assays.
The experimental details may differ.
Experiment A (known measurement)
<SMILES>O=C1CN(N=Cc2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)N1</SMILES>
- Assay system: MDR1_ZFN MDCKII bidirectional transport assay
- Endpoint: efflux_or_secretory_transport
- Known sourc... | (B) | train | 8d1577f032231c3fbf69ff76d219022834456433069dae538f1c04d550a8cce4 | -1 | null | -1 | null | null | null | bioavailability_ma | fg | minority_first_separate_family_caps_repair_binary_75_25.v24.2 | bioavailability_ma:114a736f05a78d7d7faf4cba52eb19a734cf27d07ea7d25381d343d99c4145a3 | bioavailability_ma:99f3c25ff26540afac6b52fbd8976a78ef6859d5e362dbff41e88c5d4439b501 | bioavailability_ma:114a736f05a78d7d7faf4cba52eb19a734cf27d07ea7d25381d343d99c4145a3 | bioavailability_ma:99f3c25ff26540afac6b52fbd8976a78ef6859d5e362dbff41e88c5d4439b501 | YBHILYKTIRIUTE-UHFFFAOYSA-N | OZOMQRBLCMDCEG-UHFFFAOYSA-N | COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-] | O=C1CN(N=Cc2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)N1 | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | exact_v10_pair_bucket_and_level | exact_v10_pair_bucket_and_level | [
"Assay system=MDR1-MDCK monolayer",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=berberine hydrochloride",
"Qualifying conditions=coformulated with natural nanoparticles",
"Transporter or enzyme=P-gp"
] | [
"Assay system=MDR1_ZFN MDCKII bidirectional transport assay",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=dantrolene",
"Transporter or enzyme=MDR1/ABCB1"
] | same_exact_v10_pair_bucket_and_level | 1 | 1 | null | null | 1 | 0 | far | 1 | 0 | 1 | null | {
"nontransfer": 0.9276884331807846,
"transfer": 0.07231156681921541
} | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | L5 | binary | {
"calibration_sha256": "ba5f07c876284074163b9ec5a6e974ff8b00efecae4679c6e0cbab7b47d0d8a0",
"groups": {
"assay_concept": "L5",
"measurement_kind": "binary",
"query_condition_group": "[\"fg\",\"efflux_or_secretory_transport\",\"binary_outcome_class\",\"fg_substrate_status_binary.v1\",\"ABCB1\",\"mdck\",\... | 1 | null | 0.072312 | null | 0.072312 | 0.927688 | query_disjoint_ratio_conflict_gated.v25 | 0 | true | 0.058824 | -1 | -1 | -1 | fg | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | YBHILYKTIRIUTE-UHFFFAOYSA-N | OZOMQRBLCMDCEG-UHFFFAOYSA-N | c1ccc2c[n+]3c(cc2c1)-c1cc2c(cc1CC3)OCO2 | O=C1CN(N=Cc2ccc(-c3ccccc3)o2)C(=O)N1 | {
"aggregation_method": "individual_record",
"display_measurement_text": "efflux ratio decreased from 25.8 to 17.1",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 1,
"aggregate_max": 1,
"aggregate_q1"... | {
"aggregation_method": "individual_record",
"display_measurement_text": "ER < 2",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 0,
"aggregate_max": 0,
"aggregate_q1": 0,
"aggregate_q3": 0
} | 219 | 191 | 107 | id | train_only_exact_bucket.v24 | identity | {"assay_system":"MDR1-MDCK monolayer","confidence":0.96,"endpoint_name":"efflux_or_secretory_transport","extra_details":null,"extraction_id":"ext_9","global_identifier":"SMILES:2345041","intestinal_site":null,"measurement_text":"efflux ratio decreased from 25.8 to 17.1","molecule_name":"berberine hydrochloride","paragr... | {"assay_system":"MDR1_ZFN MDCKII bidirectional transport assay","confidence":0.9,"endpoint_name":"efflux_or_secretory_transport","extra_details":null,"extraction_id":"ext_30","global_identifier":"SMILES:3793980","intestinal_site":null,"measurement_text":"ER < 2","molecule_name":"dantrolene","paragraph_idx":60,"pmid":"3... | L5 | gut_wall_efflux_intestinal_metabolism | sr_e62e36898f0248f28d38df6e2ba3b704 | sr_c49c711a4bf6468e8239a62b4f0d03a5 | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__"] | |
You are comparing two experiments selected from similar assays.
The experimental details may differ.
Experiment A (known measurement)
<SMILES>O=C(O)[C@H]1/C(=C/CO)O[C@@H]2CC(=O)N21</SMILES>
- Assay system: MDCK-chAbcb1 and MDCK-chAbcg2 stable transfected cell lines
- Endpoint: efflux_or_secretory_transport
- Extra det... | (B) | train | ace2b8b753dd21918478584e92f5e7bed4ce8a1edc5a24485c676a2ca677a596 | -1 | null | -1 | null | null | null | bioavailability_ma | fg | minority_first_separate_family_caps_repair_binary_75_25.v24.2 | bioavailability_ma:114a736f05a78d7d7faf4cba52eb19a734cf27d07ea7d25381d343d99c4145a3 | bioavailability_ma:e8c934802ee175c21b7367830a3159882688639b62fcc41c0bacfbb2b80469b2 | bioavailability_ma:114a736f05a78d7d7faf4cba52eb19a734cf27d07ea7d25381d343d99c4145a3 | bioavailability_ma:e8c934802ee175c21b7367830a3159882688639b62fcc41c0bacfbb2b80469b2 | YBHILYKTIRIUTE-UHFFFAOYSA-N | HZZVJAQRINQKSD-PBFISZAISA-N | COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-] | O=C(O)[C@H]1/C(=C/CO)O[C@@H]2CC(=O)N21 | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | exact_v10_pair_bucket_and_level | exact_v10_pair_bucket_and_level | [
"Assay system=MDR1-MDCK monolayer",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=berberine hydrochloride",
"Qualifying conditions=coformulated with natural nanoparticles",
"Transporter or enzyme=P-gp"
] | [
"Assay system=MDCK-chAbcb1 and MDCK-chAbcg2 stable transfected cell lines",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=Amoxicillin",
"Qualifying conditions=stable MDCK cells expressing chicken transporters",
"Transporter or enzyme=P-gp/ABCB1"
] | same_exact_v10_pair_bucket_and_level | 1 | 1 | null | null | 1 | 0 | far | 1 | 0 | 1 | null | {
"nontransfer": 0.9276884331807846,
"transfer": 0.07231156681921541
} | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | L5 | binary | {
"calibration_sha256": "ba5f07c876284074163b9ec5a6e974ff8b00efecae4679c6e0cbab7b47d0d8a0",
"groups": {
"assay_concept": "L5",
"measurement_kind": "binary",
"query_condition_group": "[\"fg\",\"efflux_or_secretory_transport\",\"binary_outcome_class\",\"fg_substrate_status_binary.v1\",\"ABCB1\",\"mdck\",\... | 1 | null | 0.072312 | null | 0.072312 | 0.927688 | query_disjoint_ratio_conflict_gated.v25 | 0 | true | 0.067568 | -1 | -1 | -1 | fg | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | YBHILYKTIRIUTE-UHFFFAOYSA-N | HZZVJAQRINQKSD-PBFISZAISA-N | c1ccc2c[n+]3c(cc2c1)-c1cc2c(cc1CC3)OCO2 | C=C1CN2C(=O)CC2O1 | {
"aggregation_method": "individual_record",
"display_measurement_text": "efflux ratio decreased from 25.8 to 17.1",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 1,
"aggregate_max": 1,
"aggregate_q1"... | {
"aggregation_method": "individual_record",
"display_measurement_text": "",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 0,
"aggregate_max": 0,
"aggregate_q1": 0,
"aggregate_q3": 0
} | 219 | 191 | 107 | id | train_only_exact_bucket.v24 | identity | {"assay_system":"MDR1-MDCK monolayer","confidence":0.96,"endpoint_name":"efflux_or_secretory_transport","extra_details":null,"extraction_id":"ext_9","global_identifier":"SMILES:2345041","intestinal_site":null,"measurement_text":"efflux ratio decreased from 25.8 to 17.1","molecule_name":"berberine hydrochloride","paragr... | {"assay_system":"MDCK-chAbcb1 and MDCK-chAbcg2 stable transfected cell lines","confidence":0.94,"endpoint_name":"efflux_or_secretory_transport","extra_details":"No net efflux ratio >2 observed for either transporter.","extraction_id":"ext_14","global_identifier":"SMILES:3640303","intestinal_site":null,"measurement_text... | L5 | gut_wall_efflux_intestinal_metabolism | sr_e62e36898f0248f28d38df6e2ba3b704 | sr_c3b97ba4983041ca8f80f52ad2ab4c73 | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__"] | |
You are comparing two experiments selected from similar assays.
The experimental details may differ.
Experiment A (known measurement)
<SMILES>O=c1c(O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12</SMILES>
- Assay system: MDCK cell monolayer transport assay
- Endpoint: efflux_or_secretory_t... | (B) | train | b3a6e8b232b8afb144ea42837fb6721f67f02b4977487280259146ed06f7acd8 | -1 | null | -1 | null | null | null | bioavailability_ma | fg | minority_first_separate_family_caps_repair_binary_75_25.v24.2 | bioavailability_ma:114a736f05a78d7d7faf4cba52eb19a734cf27d07ea7d25381d343d99c4145a3 | bioavailability_ma:743d9e426bc97f4f2a88a75571727077046bc21aaedf91572840bdcf804d5c46 | bioavailability_ma:114a736f05a78d7d7faf4cba52eb19a734cf27d07ea7d25381d343d99c4145a3 | bioavailability_ma:743d9e426bc97f4f2a88a75571727077046bc21aaedf91572840bdcf804d5c46 | YBHILYKTIRIUTE-UHFFFAOYSA-N | OVSQVDMCBVZWGM-DTGCRPNFSA-N | COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-] | O=c1c(O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | exact_v10_pair_bucket_and_level | exact_v10_pair_bucket_and_level | [
"Assay system=MDR1-MDCK monolayer",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=berberine hydrochloride",
"Qualifying conditions=coformulated with natural nanoparticles",
"Transporter or enzyme=P-gp"
] | [
"Assay system=MDCK cell monolayer transport assay",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=Q-3-gal",
"Qualifying conditions=50 µM verapamil",
"Transporter or enzyme=P-gp/ABCB1"
] | same_exact_v10_pair_bucket_and_level | 1 | 1 | null | null | 1 | 0 | far | 1 | 0 | 1 | null | {
"nontransfer": 0.9276884331807846,
"transfer": 0.07231156681921541
} | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | L5 | binary | {
"calibration_sha256": "ba5f07c876284074163b9ec5a6e974ff8b00efecae4679c6e0cbab7b47d0d8a0",
"groups": {
"assay_concept": "L5",
"measurement_kind": "binary",
"query_condition_group": "[\"fg\",\"efflux_or_secretory_transport\",\"binary_outcome_class\",\"fg_substrate_status_binary.v1\",\"ABCB1\",\"mdck\",\... | 1 | null | 0.072312 | null | 0.072312 | 0.927688 | query_disjoint_ratio_conflict_gated.v25 | 0 | true | 0.087912 | -1 | -1 | -1 | fg | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | YBHILYKTIRIUTE-UHFFFAOYSA-N | OVSQVDMCBVZWGM-DTGCRPNFSA-N | c1ccc2c[n+]3c(cc2c1)-c1cc2c(cc1CC3)OCO2 | O=c1c(OC2CCCCO2)c(-c2ccccc2)oc2ccccc12 | {
"aggregation_method": "individual_record",
"display_measurement_text": "efflux ratio decreased from 25.8 to 17.1",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 1,
"aggregate_max": 1,
"aggregate_q1"... | {
"aggregation_method": "individual_record",
"display_measurement_text": "no effect of 50 µM verapamil on transport in both directions",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 0,
"aggregate_max":... | 219 | 191 | 107 | id | train_only_exact_bucket.v24 | identity | {"assay_system":"MDR1-MDCK monolayer","confidence":0.96,"endpoint_name":"efflux_or_secretory_transport","extra_details":null,"extraction_id":"ext_9","global_identifier":"SMILES:2345041","intestinal_site":null,"measurement_text":"efflux ratio decreased from 25.8 to 17.1","molecule_name":"berberine hydrochloride","paragr... | {"assay_system":"MDCK cell monolayer transport assay","confidence":0.96,"endpoint_name":"efflux_or_secretory_transport","extra_details":null,"extraction_id":"ext_44","global_identifier":"SMILES:4019378","intestinal_site":null,"measurement_text":"no effect of 50 µM verapamil on transport in both directions","molecule_na... | L5 | gut_wall_efflux_intestinal_metabolism | sr_e62e36898f0248f28d38df6e2ba3b704 | sr_0c69d1cf05d447c2b103b6e2230e975b | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__"] | |
You are comparing two experiments selected from similar assays.
The experimental details may differ.
Experiment A (known measurement)
<SMILES>C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OCCc3ccc(O)c(O)c3)[C@H](O)[C@@H](O)[C@@H]2OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H](O)[C@H](O)[C@H]1O</SMILES>
- Assay system: MDCKII-MDR1 transfected cell... | (B) | train | b2a9f744ac65e1024afb73ec5ce1e68c1ec25218d3e1a751abd1b45b5b8c0bc0 | -1 | null | -1 | null | null | null | bioavailability_ma | fg | minority_first_separate_family_caps_repair_binary_75_25.v24.2 | bioavailability_ma:114a736f05a78d7d7faf4cba52eb19a734cf27d07ea7d25381d343d99c4145a3 | bioavailability_ma:d9b198ac669919c34b85a4ddebc86cab0a287f4c878e7d5e21fbb7aa50a357e3 | bioavailability_ma:114a736f05a78d7d7faf4cba52eb19a734cf27d07ea7d25381d343d99c4145a3 | bioavailability_ma:d9b198ac669919c34b85a4ddebc86cab0a287f4c878e7d5e21fbb7aa50a357e3 | YBHILYKTIRIUTE-UHFFFAOYSA-N | DTOUWTJYUCZJQD-UJERWXFOSA-N | COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-] | C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OCCc3ccc(O)c(O)c3)[C@H](O)[C@@H](O)[C@@H]2OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H](O)[C@H](O)[C@H]1O | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | exact_v10_pair_bucket_and_level | exact_v10_pair_bucket_and_level | [
"Assay system=MDR1-MDCK monolayer",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=berberine hydrochloride",
"Qualifying conditions=coformulated with natural nanoparticles",
"Transporter or enzyme=P-gp"
] | [
"Assay system=MDCKII-MDR1 transfected cell monolayer",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=Forsythiaside",
"Transporter or enzyme=P-gp/ABCB1"
] | same_exact_v10_pair_bucket_and_level | 1 | 1 | null | null | 1 | 0 | far | 1 | 0 | 1 | null | {
"nontransfer": 0.9276884331807846,
"transfer": 0.07231156681921541
} | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | L5 | binary | {
"calibration_sha256": "ba5f07c876284074163b9ec5a6e974ff8b00efecae4679c6e0cbab7b47d0d8a0",
"groups": {
"assay_concept": "L5",
"measurement_kind": "binary",
"query_condition_group": "[\"fg\",\"efflux_or_secretory_transport\",\"binary_outcome_class\",\"fg_substrate_status_binary.v1\",\"ABCB1\",\"mdck\",\... | 1 | null | 0.072312 | null | 0.072312 | 0.927688 | query_disjoint_ratio_conflict_gated.v25 | 0 | true | 0.07 | -1 | -1 | -1 | fg | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | YBHILYKTIRIUTE-UHFFFAOYSA-N | DTOUWTJYUCZJQD-UJERWXFOSA-N | c1ccc2c[n+]3c(cc2c1)-c1cc2c(cc1CC3)OCO2 | O=C(C=Cc1ccccc1)OC1CCC(OCCc2ccccc2)OC1COC1CCCCO1 | {
"aggregation_method": "individual_record",
"display_measurement_text": "efflux ratio decreased from 25.8 to 17.1",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 1,
"aggregate_max": 1,
"aggregate_q1"... | {
"aggregation_method": "individual_record",
"display_measurement_text": "no significant reduction in efflux ratio",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 0,
"aggregate_max": 0,
"aggregate_q1"... | 219 | 191 | 107 | id | train_only_exact_bucket.v24 | identity | {"assay_system":"MDR1-MDCK monolayer","confidence":0.96,"endpoint_name":"efflux_or_secretory_transport","extra_details":null,"extraction_id":"ext_9","global_identifier":"SMILES:2345041","intestinal_site":null,"measurement_text":"efflux ratio decreased from 25.8 to 17.1","molecule_name":"berberine hydrochloride","paragr... | {"assay_system":"MDCKII-MDR1 transfected cell monolayer","confidence":0.95,"endpoint_name":"efflux_or_secretory_transport","extra_details":"Suggests low affinity for P‐gp mediated efflux.","extraction_id":"ext_4","global_identifier":"SMILES:2491105","intestinal_site":null,"measurement_text":"no significant reduction in... | L5 | gut_wall_efflux_intestinal_metabolism | sr_e62e36898f0248f28d38df6e2ba3b704 | sr_69872b4875fd4b8bb99ea08d5b93c2f8 | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__"] | |
You are comparing two experiments selected from similar assays.
The experimental details may differ.
Experiment A (known measurement)
<SMILES>CC(C)NC[C@H](O)COc1cccc2ccccc12</SMILES>
- Assay system: MDCK-MDR1 bidirectional transport
- Endpoint: efflux_or_secretory_transport
- Extra details: Efflux ratio remained below... | (B) | train | 7bb14d03342408776206d737a7fdc9832ffa5d4cdc5aa1f745873ab4cf3fa5d6 | -1 | null | -1 | null | null | null | bioavailability_ma | fg | minority_first_separate_family_caps_repair_binary_75_25.v24.2 | bioavailability_ma:114a736f05a78d7d7faf4cba52eb19a734cf27d07ea7d25381d343d99c4145a3 | bioavailability_ma:fb31a34ede113ee8b486030f030e5836f59740e69153dff32a495d586474939a | bioavailability_ma:114a736f05a78d7d7faf4cba52eb19a734cf27d07ea7d25381d343d99c4145a3 | bioavailability_ma:fb31a34ede113ee8b486030f030e5836f59740e69153dff32a495d586474939a | YBHILYKTIRIUTE-UHFFFAOYSA-N | AQHHHDLHHXJYJD-AWEZNQCLSA-N | COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-] | CC(C)NC[C@H](O)COc1cccc2ccccc12 | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | exact_v10_pair_bucket_and_level | exact_v10_pair_bucket_and_level | [
"Assay system=MDR1-MDCK monolayer",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=berberine hydrochloride",
"Qualifying conditions=coformulated with natural nanoparticles",
"Transporter or enzyme=P-gp"
] | [
"Assay system=MDCK-MDR1 bidirectional transport",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=S-propranolol",
"Qualifying conditions=P-gp inhibitor GG918 present; concentration 25 nM",
"Transporter or enzyme=P-gp/ABCB1"
] | same_exact_v10_pair_bucket_and_level | 1 | 1 | null | null | 1 | 0 | far | 1 | 0 | 1 | null | {
"nontransfer": 0.9276884331807846,
"transfer": 0.07231156681921541
} | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | L5 | binary | {
"calibration_sha256": "ba5f07c876284074163b9ec5a6e974ff8b00efecae4679c6e0cbab7b47d0d8a0",
"groups": {
"assay_concept": "L5",
"measurement_kind": "binary",
"query_condition_group": "[\"fg\",\"efflux_or_secretory_transport\",\"binary_outcome_class\",\"fg_substrate_status_binary.v1\",\"ABCB1\",\"mdck\",\... | 1 | null | 0.072312 | null | 0.072312 | 0.927688 | query_disjoint_ratio_conflict_gated.v25 | 0 | true | 0.125 | -1 | -1 | -1 | fg | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | YBHILYKTIRIUTE-UHFFFAOYSA-N | AQHHHDLHHXJYJD-AWEZNQCLSA-N | c1ccc2c[n+]3c(cc2c1)-c1cc2c(cc1CC3)OCO2 | c1ccc2ccccc2c1 | {
"aggregation_method": "individual_record",
"display_measurement_text": "efflux ratio decreased from 25.8 to 17.1",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 1,
"aggregate_max": 1,
"aggregate_q1"... | {
"aggregation_method": "individual_record",
"display_measurement_text": "no increase in transport with GG918 at 25 nM",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 0,
"aggregate_max": 0,
"aggregate... | 219 | 191 | 107 | id | train_only_exact_bucket.v24 | identity | {"assay_system":"MDR1-MDCK monolayer","confidence":0.96,"endpoint_name":"efflux_or_secretory_transport","extra_details":null,"extraction_id":"ext_9","global_identifier":"SMILES:2345041","intestinal_site":null,"measurement_text":"efflux ratio decreased from 25.8 to 17.1","molecule_name":"berberine hydrochloride","paragr... | {"assay_system":"MDCK-MDR1 bidirectional transport","confidence":0.95,"endpoint_name":"efflux_or_secretory_transport","extra_details":"Efflux ratio remained below 1, supporting lack of P‐gp substrate activity.","extraction_id":"ext_24","global_identifier":"SMILES:703956","intestinal_site":null,"measurement_text":"no in... | L5 | gut_wall_efflux_intestinal_metabolism | sr_e62e36898f0248f28d38df6e2ba3b704 | sr_eac842ac85544607977dbad2d733453a | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__"] | |
You are comparing two experiments selected from similar assays.
The experimental details may differ.
Experiment A (known measurement)
<SMILES>O=c1c(O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12</SMILES>
- Assay system: MDCK cell monolayer transport assay
- Endpoint: efflux_or_secretory_tran... | (B) | train | 9cd51cd05036b576f80bbc90d584e3d6a8f86e43ff086b3053208371973f58b3 | -1 | null | -1 | null | null | null | bioavailability_ma | fg | minority_first_separate_family_caps_repair_binary_75_25.v24.2 | bioavailability_ma:114a736f05a78d7d7faf4cba52eb19a734cf27d07ea7d25381d343d99c4145a3 | bioavailability_ma:8f6c0f0e9b47df04943a20d4d12da399944d265aa857536db97722ec3b9b5883 | bioavailability_ma:114a736f05a78d7d7faf4cba52eb19a734cf27d07ea7d25381d343d99c4145a3 | bioavailability_ma:8f6c0f0e9b47df04943a20d4d12da399944d265aa857536db97722ec3b9b5883 | YBHILYKTIRIUTE-UHFFFAOYSA-N | JPUKWEQWGBDDQB-DTGCRPNFSA-N | COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-] | O=c1c(O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12 | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | exact_v10_pair_bucket_and_level | exact_v10_pair_bucket_and_level | [
"Assay system=MDR1-MDCK monolayer",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=berberine hydrochloride",
"Qualifying conditions=coformulated with natural nanoparticles",
"Transporter or enzyme=P-gp"
] | [
"Assay system=MDCK cell monolayer transport assay",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=K-3-gal",
"Qualifying conditions=50 µM verapamil",
"Transporter or enzyme=P-gp/ABCB1"
] | same_exact_v10_pair_bucket_and_level | 1 | 1 | null | null | 1 | 0 | far | 1 | 0 | 1 | null | {
"nontransfer": 0.9276884331807846,
"transfer": 0.07231156681921541
} | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | L5 | binary | {
"calibration_sha256": "ba5f07c876284074163b9ec5a6e974ff8b00efecae4679c6e0cbab7b47d0d8a0",
"groups": {
"assay_concept": "L5",
"measurement_kind": "binary",
"query_condition_group": "[\"fg\",\"efflux_or_secretory_transport\",\"binary_outcome_class\",\"fg_substrate_status_binary.v1\",\"ABCB1\",\"mdck\",\... | 1 | null | 0.072312 | null | 0.072312 | 0.927688 | query_disjoint_ratio_conflict_gated.v25 | 0 | true | 0.089888 | -1 | -1 | -1 | fg | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | YBHILYKTIRIUTE-UHFFFAOYSA-N | JPUKWEQWGBDDQB-DTGCRPNFSA-N | c1ccc2c[n+]3c(cc2c1)-c1cc2c(cc1CC3)OCO2 | O=c1c(OC2CCCCO2)c(-c2ccccc2)oc2ccccc12 | {
"aggregation_method": "individual_record",
"display_measurement_text": "efflux ratio decreased from 25.8 to 17.1",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 1,
"aggregate_max": 1,
"aggregate_q1"... | {
"aggregation_method": "individual_record",
"display_measurement_text": "no effect of 50 µM verapamil on transport in both directions",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 0,
"aggregate_max":... | 219 | 191 | 107 | id | train_only_exact_bucket.v24 | identity | {"assay_system":"MDR1-MDCK monolayer","confidence":0.96,"endpoint_name":"efflux_or_secretory_transport","extra_details":null,"extraction_id":"ext_9","global_identifier":"SMILES:2345041","intestinal_site":null,"measurement_text":"efflux ratio decreased from 25.8 to 17.1","molecule_name":"berberine hydrochloride","paragr... | {"assay_system":"MDCK cell monolayer transport assay","confidence":0.96,"endpoint_name":"efflux_or_secretory_transport","extra_details":null,"extraction_id":"ext_46","global_identifier":"SMILES:4019384","intestinal_site":null,"measurement_text":"no effect of 50 µM verapamil on transport in both directions","molecule_na... | L5 | gut_wall_efflux_intestinal_metabolism | sr_e62e36898f0248f28d38df6e2ba3b704 | sr_9196854d831044c9aa15bf03e33f7893 | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__"] | |
You are comparing two experiments selected from similar assays.
The experimental details may differ.
Experiment A (known measurement)
<SMILES>C/C(C(=O)[O-])=C(/C)C(=O)[O-]</SMILES>
- Assay system: MDCKII‐MDR1 cell monolayer permeability assay (WT vs MDR1‐transfected)
- Endpoint: efflux_or_secretory_transport
- Extra d... | (B) | train | 7e044634a5d50a471969b7dfb4e6181f99b66233acf613e28ec019f72a644d65 | -1 | null | -1 | null | null | null | bioavailability_ma | fg | minority_first_separate_family_caps_repair_binary_75_25.v24.2 | bioavailability_ma:114a736f05a78d7d7faf4cba52eb19a734cf27d07ea7d25381d343d99c4145a3 | bioavailability_ma:26699ab8f03428c51584539fa081073ac0f20e8b18283ed127fc8f70f66a76d7 | bioavailability_ma:114a736f05a78d7d7faf4cba52eb19a734cf27d07ea7d25381d343d99c4145a3 | bioavailability_ma:26699ab8f03428c51584539fa081073ac0f20e8b18283ed127fc8f70f66a76d7 | YBHILYKTIRIUTE-UHFFFAOYSA-N | CGBYBGVMDAPUIH-ONEGZZNKSA-N | COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-] | C/C(C(=O)[O-])=C(/C)C(=O)[O-] | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | exact_v10_pair_bucket_and_level | exact_v10_pair_bucket_and_level | [
"Assay system=MDR1-MDCK monolayer",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=berberine hydrochloride",
"Qualifying conditions=coformulated with natural nanoparticles",
"Transporter or enzyme=P-gp"
] | [
"Assay system=MDCKII‐MDR1 cell monolayer permeability assay (WT vs MDR1‐transfected)",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=Dimethyl fumarate",
"Qualifying conditions=comparison between wild‐type and MDR1‐transfected MDCKII cells",
"Transporter or enzyme=P‐gp/ABCB1"
] | same_exact_v10_pair_bucket_and_level | 1 | 1 | null | null | 1 | 0 | far | 1 | 0 | 1 | null | {
"nontransfer": 0.9276884331807846,
"transfer": 0.07231156681921541
} | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | L5 | binary | {
"calibration_sha256": "ba5f07c876284074163b9ec5a6e974ff8b00efecae4679c6e0cbab7b47d0d8a0",
"groups": {
"assay_concept": "L5",
"measurement_kind": "binary",
"query_condition_group": "[\"fg\",\"efflux_or_secretory_transport\",\"binary_outcome_class\",\"fg_substrate_status_binary.v1\",\"ABCB1\",\"mdck\",\... | 1 | null | 0.072312 | null | 0.072312 | 0.927688 | query_disjoint_ratio_conflict_gated.v25 | 0 | true | 0.018182 | -1 | -1 | -1 | fg | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | YBHILYKTIRIUTE-UHFFFAOYSA-N | CGBYBGVMDAPUIH-ONEGZZNKSA-N | c1ccc2c[n+]3c(cc2c1)-c1cc2c(cc1CC3)OCO2 | parent:CGBYBGVMDAPUIH-ONEGZZNKSA-N | {
"aggregation_method": "individual_record",
"display_measurement_text": "efflux ratio decreased from 25.8 to 17.1",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 1,
"aggregate_max": 1,
"aggregate_q1"... | {
"aggregation_method": "individual_record",
"display_measurement_text": "negligible difference in permeability between WT and MDR1‐transfected cells",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 0,
"... | 219 | 191 | 107 | id | train_only_exact_bucket.v24 | identity | {"assay_system":"MDR1-MDCK monolayer","confidence":0.96,"endpoint_name":"efflux_or_secretory_transport","extra_details":null,"extraction_id":"ext_9","global_identifier":"SMILES:2345041","intestinal_site":null,"measurement_text":"efflux ratio decreased from 25.8 to 17.1","molecule_name":"berberine hydrochloride","paragr... | {"assay_system":"MDCKII‐MDR1 cell monolayer permeability assay (WT vs MDR1‐transfected)","confidence":0.96,"endpoint_name":"efflux_or_secretory_transport","extra_details":"Net efflux ratio for digoxin was >2 × 10−6 cm/s and decreased with verapamil; atenolol and propranolol were used as control compounds.","extraction_... | L5 | gut_wall_efflux_intestinal_metabolism | sr_e62e36898f0248f28d38df6e2ba3b704 | sr_0d699116cd074ec3bce547354ea1f794 | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__"] | |
You are comparing two experiments selected from similar assays.
The experimental details may differ.
Experiment A (known measurement)
<SMILES>CS(=O)(=O)c1ccc(Oc2cc(F)cc(C#N)c2)c2c1[C@H](O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O)C(F)(F)C2</SMILES>
- Assay system: MDCKII-MDR1 bidirectional transport assay
- Endpoin... | (B) | train | b131e12bd4a755566dbed759d06c231a516956e3fd0a6bd6f65bccdafdbfa076 | -1 | null | -1 | null | null | null | bioavailability_ma | fg | minority_first_separate_family_caps_repair_binary_75_25.v24.2 | bioavailability_ma:114a736f05a78d7d7faf4cba52eb19a734cf27d07ea7d25381d343d99c4145a3 | bioavailability_ma:c535f6d0b916a11f78db1765579db1d02805d1d9ee773a50fcf6ce845b825a91 | bioavailability_ma:114a736f05a78d7d7faf4cba52eb19a734cf27d07ea7d25381d343d99c4145a3 | bioavailability_ma:c535f6d0b916a11f78db1765579db1d02805d1d9ee773a50fcf6ce845b825a91 | YBHILYKTIRIUTE-UHFFFAOYSA-N | XGIGYSOPEMLXCF-GFMQMUGXSA-N | COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-] | CS(=O)(=O)c1ccc(Oc2cc(F)cc(C#N)c2)c2c1[C@H](O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O)C(F)(F)C2 | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | exact_v10_pair_bucket_and_level | exact_v10_pair_bucket_and_level | [
"Assay system=MDR1-MDCK monolayer",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=berberine hydrochloride",
"Qualifying conditions=coformulated with natural nanoparticles",
"Transporter or enzyme=P-gp"
] | [
"Assay system=MDCKII-MDR1 bidirectional transport assay",
"Endpoint=efflux_or_secretory_transport",
"Molecule name=PT2639",
"Transporter or enzyme=P-gp"
] | same_exact_v10_pair_bucket_and_level | 1 | 1 | null | null | 1 | 0 | far | 1 | 0 | 1 | null | {
"nontransfer": 0.9276884331807846,
"transfer": 0.07231156681921541
} | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | L5 | binary | {
"calibration_sha256": "ba5f07c876284074163b9ec5a6e974ff8b00efecae4679c6e0cbab7b47d0d8a0",
"groups": {
"assay_concept": "L5",
"measurement_kind": "binary",
"query_condition_group": "[\"fg\",\"efflux_or_secretory_transport\",\"binary_outcome_class\",\"fg_substrate_status_binary.v1\",\"ABCB1\",\"mdck\",\... | 1 | null | 0.072312 | null | 0.072312 | 0.927688 | query_disjoint_ratio_conflict_gated.v25 | 0 | true | 0.127451 | -1 | -1 | -1 | fg | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__","L5"] | YBHILYKTIRIUTE-UHFFFAOYSA-N | XGIGYSOPEMLXCF-GFMQMUGXSA-N | c1ccc2c[n+]3c(cc2c1)-c1cc2c(cc1CC3)OCO2 | c1ccc(Oc2cccc3c2CCC3OC2CCCCO2)cc1 | {
"aggregation_method": "individual_record",
"display_measurement_text": "efflux ratio decreased from 25.8 to 17.1",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 1,
"aggregate_max": 1,
"aggregate_q1"... | {
"aggregation_method": "individual_record",
"display_measurement_text": "efflux ratio <2 up to 300 µM",
"display_unit_text": "",
"display_transform_id": "source_native",
"source_record_count": 1,
"deduplicated_source_record_count": 1,
"aggregate_min": 0,
"aggregate_max": 0,
"aggregate_q1": 0,
"aggr... | 219 | 191 | 107 | id | train_only_exact_bucket.v24 | identity | {"assay_system":"MDR1-MDCK monolayer","confidence":0.96,"endpoint_name":"efflux_or_secretory_transport","extra_details":null,"extraction_id":"ext_9","global_identifier":"SMILES:2345041","intestinal_site":null,"measurement_text":"efflux ratio decreased from 25.8 to 17.1","molecule_name":"berberine hydrochloride","paragr... | {"assay_system":"MDCKII-MDR1 bidirectional transport assay","confidence":0.94,"endpoint_name":"efflux_or_secretory_transport","extra_details":null,"extraction_id":"ext_5","global_identifier":"SMILES:2426468","intestinal_site":null,"measurement_text":"efflux ratio <2 up to 300 µM","molecule_name":"PT2639","paragraph_idx... | L5 | gut_wall_efflux_intestinal_metabolism | sr_e62e36898f0248f28d38df6e2ba3b704 | sr_948fd21e5dd349f8b7d76e7bc5322c3a | ["fg","efflux_or_secretory_transport","binary_outcome_class","fg_substrate_status_binary.v1","ABCB1","mdck","__unknown__"] |
Oral bioavailability V25
Independent L2-L6 releases derived from the frozen consolidated oral V24.1 splits. Record degree is 24 for L5 and six for L2/L3/L4/L6, separately for query and reference roles. Parent molecule budgets remain 4096 per role, level, and binary/nonbinary family. Minority-first sampling, compatible-endpoint repair, and final binary 75/25 trimming are retained. Low degree and binary trimming can leave records unused; see record_coverage.json.
The entire official validation and test connected scaffold universes are excluded from training across all levels, including records not selected as evaluation queries. Evaluation membership and reference ordering match oral V24.1: 500 total queries per level per split, Morgan top-50 ID references, and complete OOD pools.
Conflict exclusions, support thresholds, reviewed identity/log10 geometry, and the ratio gate <=0.5 (undefined rejected) are preserved. Test measurements only participate in the inherited eligibility gate, not training target fitting. Numeric targets retain center 0.4 SD and temperature 0.1. Binary soft targets are refitted globally within each level from the final numeric training pairs, and all training, validation, and test rows are rendered using those updated targets. Internal v24.2 sampler/schema names identify reused algorithms, not the release.
Level: L5
Pair rows: {'train': 29954, 'validation_ranking': 23836, 'test_ranking': 22957}
- Downloads last month
- 48